Page last updated: 2024-08-21

alpha-aminopyridine and Leukemia, Lymphocytic, T Cell

alpha-aminopyridine has been researched along with Leukemia, Lymphocytic, T Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Behrmann, CA; Ennis, KN; Feng, X; Jiang, TT; Kofuji, S; Liu, H; Niu, L; Plas, DR; Sarma, P; Sasaki, AT; Stratton, Y; Thomas, HE; Yoon, SO	1

Other Studies

1 other study(ies) available for alpha-aminopyridine and Leukemia, Lymphocytic, T Cell

Article	Year
Pharmacologic Targeting of S6K1 in PTEN-Deficient Neoplasia. Cell reports, 2017, 02-28, Volume: 18, Issue:9 Topics: Aminopyridines; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Gene Knockdown Techniques; Glioblastoma; Heterocyclic Compounds, 4 or More Rings; Humans; Leukemia, T-Cell; Mice; Neoplasms; Phosphorylation; PTEN Phosphohydrolase; Pyridones; Receptor Protein-Tyrosine Kinases; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; TOR Serine-Threonine Kinases	2017

Article

Year

Pharmacologic Targeting of S6K1 in PTEN-Deficient Neoplasia.

Cell reports, 2017, 02-28, Volume: 18, Issue:9

Topics: Aminopyridines; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Gene Knockdown Techniques; Glioblastoma; Heterocyclic Compounds, 4 or More Rings; Humans; Leukemia, T-Cell; Mice; Neoplasms; Phosphorylation; PTEN Phosphohydrolase; Pyridones; Receptor Protein-Tyrosine Kinases; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; TOR Serine-Threonine Kinases

2017